Terms: = Liver cancer AND MITF, WS2A, ENSG00000187098, 4286 AND Prognosis
4 results:
1. Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression.
Kammerer-Jacquet SF; Gandon C; Dugay F; Laguerre B; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Leroy X; Aubert S; Vermaut C; Escande F; Verkarre V; Compérat E; Ambrosetti D; Pedeutour F; Belaud-Rotureau MA; Rioux-Leclercq N;
Histopathology; 2022 Aug; 81(2):228-238. PubMed ID: 35562857
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulated Expression of mitf in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma.
Nooron N; Ohba K; Takeda K; Shibahara S; Chiabchalard A
Tohoku J Exp Med; 2017 Aug; 242(4):291-302. PubMed ID: 28794318
[TBL] [Abstract] [Full Text] [Related]
3. Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy.
Shustef E; Torres-Cabala CA; Curry JL; Tetzlaff MT; Nagarajan P; Ivan D; Prieto VG; Aung PP
Am J Dermatopathol; 2017 Aug; 39(8):e116-e118. PubMed ID: 28248716
[TBL] [Abstract] [Full Text] [Related]
4. In melanoma, beta-catenin is a suppressor of invasion.
Arozarena I; Bischof H; Gilby D; Belloni B; Dummer R; Wellbrock C
Oncogene; 2011 Nov; 30(45):4531-43. PubMed ID: 21577209
[TBL] [Abstract] [Full Text] [Related]
